Two distinct strategies uncovered potent inhibitors of the title enzyme. X-ray crystallography and isothermal titration calorimetry guided the systematic elaboration of fragments identified from biophysical screens. The excellent inhibitor shown in the enzyme active site on the right was formed by connection of the lead fragments (left) with an acyl sulfonamide linker and resembles the best inhibitor discovered by the fragment-growing strategy. <br/
Mycobacterium tuberculosis, the etiological agent of the infectious disease tuberculosis, kills app...
Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (...
Ligand efficiency has proven to be a valuable concept for optimization of leads in the early stages ...
Two distinct strategies uncovered potent inhibitors of the title enzyme. X-ray crystallography and i...
Get stuck in: Pantothenate synthetase is an attractive target for the development of novel small-mol...
Mycobacterium tuberculosis pantothenate synthetase is a potential anti-tuberculosis target, and a hi...
The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium tuberculosis...
<div><p>The enzyme pantothenate synthetase, PanC, is an attractive drug target in <i>Mycobacterium t...
Pantothenate synthetase (PS; EC 6.3.2.1), encoded by the panC gene, catalyzes the essential adenosin...
Ligand efficiency has proven to be a valuable concept for optimization of leads in the early stages ...
Fragment-based methods are a new and emerging approach for the discovery of protein binders that are...
A common strategy employed in antibacterial drug discovery is targeting of biosynthetic processes w...
Pantothenate kinase (PanK) catalyzes the phosphorylation of pantothenate, the first committed and ra...
In fragment-based drug discovery, the weak affinities exhibited by fragments pose significant challe...
The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium tuberculosis...
Mycobacterium tuberculosis, the etiological agent of the infectious disease tuberculosis, kills app...
Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (...
Ligand efficiency has proven to be a valuable concept for optimization of leads in the early stages ...
Two distinct strategies uncovered potent inhibitors of the title enzyme. X-ray crystallography and i...
Get stuck in: Pantothenate synthetase is an attractive target for the development of novel small-mol...
Mycobacterium tuberculosis pantothenate synthetase is a potential anti-tuberculosis target, and a hi...
The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium tuberculosis...
<div><p>The enzyme pantothenate synthetase, PanC, is an attractive drug target in <i>Mycobacterium t...
Pantothenate synthetase (PS; EC 6.3.2.1), encoded by the panC gene, catalyzes the essential adenosin...
Ligand efficiency has proven to be a valuable concept for optimization of leads in the early stages ...
Fragment-based methods are a new and emerging approach for the discovery of protein binders that are...
A common strategy employed in antibacterial drug discovery is targeting of biosynthetic processes w...
Pantothenate kinase (PanK) catalyzes the phosphorylation of pantothenate, the first committed and ra...
In fragment-based drug discovery, the weak affinities exhibited by fragments pose significant challe...
The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium tuberculosis...
Mycobacterium tuberculosis, the etiological agent of the infectious disease tuberculosis, kills app...
Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (...
Ligand efficiency has proven to be a valuable concept for optimization of leads in the early stages ...